| Dr Amol Nanasaheb Patil, MD | |
|
988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 | |
| (402) 559-4015 | |
| (402) 559-8715 |
| Full Name | Dr Amol Nanasaheb Patil |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 25 Years |
| Location | 988102 Nebraska Medical Ctr, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164575247 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 25447 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Bellevue Medical Center | Bellevue, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia - the most common type of dwarfism - in a global trial led by Melbourne's Murdoch Children's Research Institute.
One half of people using direct to consumer (DTC) personal genetic risk tests express concerns about testing yet more than 80 percent want to know their risk even for non preventable genetic diseases, according to a study in the September Genetics in Medicine, the official peer reviewed journal of The American College of Medical Genetics (ACMG).
At Angelica, we are committed to meeting the highest standards of corporate citizenship by fulfilling our mission to offer healthcare providers superior services based on our high quality products, unsurpassed quality and service standards, and creative solutions. While we strive to achieve that mission in the communities where we do business, we embrace opportunities where we can support communities outside our geographical footprint through charitable activities.
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.
An estimated 500 million people become infected with malaria each year. The disease is often lethal - particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy.
› Verified 6 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia - the most common type of dwarfism - in a global trial led by Melbourne's Murdoch Children's Research Institute.
One half of people using direct to consumer (DTC) personal genetic risk tests express concerns about testing yet more than 80 percent want to know their risk even for non preventable genetic diseases, according to a study in the September Genetics in Medicine, the official peer reviewed journal of The American College of Medical Genetics (ACMG).
At Angelica, we are committed to meeting the highest standards of corporate citizenship by fulfilling our mission to offer healthcare providers superior services based on our high quality products, unsurpassed quality and service standards, and creative solutions. While we strive to achieve that mission in the communities where we do business, we embrace opportunities where we can support communities outside our geographical footprint through charitable activities.
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.
An estimated 500 million people become infected with malaria each year. The disease is often lethal - particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy.
› Verified 6 days ago
| Entity Name | Madonna Rehabilitation Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417045642 PECOS PAC ID: 0446164081 Enrollment ID: O20031118000079 |
News Archive
A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia - the most common type of dwarfism - in a global trial led by Melbourne's Murdoch Children's Research Institute.
One half of people using direct to consumer (DTC) personal genetic risk tests express concerns about testing yet more than 80 percent want to know their risk even for non preventable genetic diseases, according to a study in the September Genetics in Medicine, the official peer reviewed journal of The American College of Medical Genetics (ACMG).
At Angelica, we are committed to meeting the highest standards of corporate citizenship by fulfilling our mission to offer healthcare providers superior services based on our high quality products, unsurpassed quality and service standards, and creative solutions. While we strive to achieve that mission in the communities where we do business, we embrace opportunities where we can support communities outside our geographical footprint through charitable activities.
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.
An estimated 500 million people become infected with malaria each year. The disease is often lethal - particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amol Nanasaheb Patil, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-4015 | Dr Amol Nanasaheb Patil, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-4015 |
News Archive
A groundbreaking drug that helps regulate bone development has boosted growth rates in children with achondroplasia - the most common type of dwarfism - in a global trial led by Melbourne's Murdoch Children's Research Institute.
One half of people using direct to consumer (DTC) personal genetic risk tests express concerns about testing yet more than 80 percent want to know their risk even for non preventable genetic diseases, according to a study in the September Genetics in Medicine, the official peer reviewed journal of The American College of Medical Genetics (ACMG).
At Angelica, we are committed to meeting the highest standards of corporate citizenship by fulfilling our mission to offer healthcare providers superior services based on our high quality products, unsurpassed quality and service standards, and creative solutions. While we strive to achieve that mission in the communities where we do business, we embrace opportunities where we can support communities outside our geographical footprint through charitable activities.
New research published today in the journal eLife has demonstrated a new method for observing the behaviour of the protein Dystrophin in a living animal cell, in real-time. This breakthrough may provide a key to understanding how to treat the genetic disease, Muscular Dystrophy.
An estimated 500 million people become infected with malaria each year. The disease is often lethal - particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy.
› Verified 6 days ago
Dr. Marium Ilahi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Dr. Vidhya Murukesan, M.B.,B.S Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250 | |
Matthew John Kapalis, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |